Terms ending in 2037
Every in-force patent on Merial, Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,905,531 | Recombinant Aav Vectors Expressing Osteoprotective Genes, Including HAS2 and Lubricin, Useful in the Treatment of Osteoarthritis and Related Joint Conditions in Mammals In force · High confidence | Genzyme Corporation | In force | High confidence | |
| US 10,188,721 | Recombinant Adenovirus Vectored FMDV Vaccines and Uses Thereof In force · High confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | High confidence | |
| US 10,493,144 | Recombinant Adenovirus Vectored FMDV Vaccines and Uses Thereof In force · High confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | High confidence | |
| US 10,663,468 | High Throughput Methods for Virus Quantification In force · High confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | High confidence | |
| US 12,083,100 | Antiparasitic Isoxazoline Compounds, Long-Acting Injectable Formulations Comprising Them, Methods and Uses Thereof In force · Medium confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | Medium confidence | |
| US 12,779,480 | Extended-Range Spray Applicator In force · High confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | High confidence | |
| US 10,342,219 | Single or Dual Technology Animal Tags and System and Method of Using the Same In force · High confidence | Boehringer Ingelheim Vetmedica GmbH | In force | High confidence | |
| US 10,433,552 | Process for the Preparation of Isoxazoline Compounds In force · High confidence | Merial, Inc. | In force | High confidence | |
| US 10,485,857 | Heartworm Vaccine, Methods and Uses Thereof In force · High confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | High confidence | |
| US 10,750,744 | Process for the Preparation of Isoxazoline Compounds In force · High confidence | Boehringer Ingelheim Animal Health USA Inc. | In force | High confidence | |
| 13 more term ends in 2037 · Pro | |||||
10 of 23 patents shown. Soonest term end first, then patent number.
Pro members see all 23.
1 of these is in force and held by Merial, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.